Daily Health News Issue # 434 for 2/26/2026
- The piece on microplastics and prostate tumors is disturbing – albeit this was a very small study. The kind of thing that points the way to a more expanded look.
- Editorial from Wall St Journal is about the seeming contradictions at the FDA – where one department is working to accelerate approval processes on one front, while another works counter to that.
- Centene using AI to optimize medical transportation routing.
- The issue of health insurance affordability is still simmering in the background – and will get front/center soon in a month or two in Congress.
See you tomorrow.
See our "top articles" list below. For a synoposis of all 37 articles curated today, see further below, and to see each of these articles listed with short summary just click here.
Click here to keep those cards and letters coming… including if you want to – gasp! – unsubscribe (please don't!)
Audio/Video
Today's Quote:
"Having seen over 300 patients with this condition over the course of my 30-year career, no one else has ever claimed or felt that they developed this condition due to a vaccination of any kind."
… — Steven Bielamowicz, director of the Voice Treatment Center at the George Washington University School of Medicine, on Health Secretary Robert F. Kennedy Jr.’s suspicion that flu vaccine triggered his voice disorder.
Today's Top Articles
Of the 37 articles curated today, here are the top 7 in our judgment:
| Article_Title | Article_Takeaway |
|---|---|
| As measles cases climb, these 9 diseases threaten comebacks | Declining vaccination rates in the U.S. are causing a resurgence of measles and threatening the comeback of other vaccine-preventable diseases. |
| Trump touts drug price reductions most Americans may not feel | Trump’s push for drug price cuts in his SOTU may not impact most Americans, despite his claims of significant reductions. |
| Microplastics found in prostate tumors in small study | A new study found microplastics in prostate cancer tumors, raising concerns about their potential role in tumor development. |
| Medicaid spending doubled in Colorado despite enrollment | A report shows Colorado’s Medicaid spending has doubled in the last decade, while enrollment only increased by 7.6%. |
| Is Centene’s (CNC) AI-Driven Transport And Community Spend Redefining Its Medicaid Moat? | Centene’s Health Net is investing in community programs and AI transport to improve Medicaid margins, but profitability restoration remains a key focus. |
| Who’s in Charge at the FDA? | An FDA commissioner’s efforts to expedite drug approvals are allegedly being undermined by the agency’s biologics chief. |
| Gene therapy is transforming lives, but for many Americans it’s hard to reach | Gene therapy offers hope, but access is limited by high costs, location, and insurance hurdles, creating disparities in treatment availability. |
Today's Graphic
Resurgence in Diseases Overseas (Source: NY Times 2/2026). See below or click here

Today's Digest
Here is a summary of all 37 articles curated today into the Competitive Research Analytics Platform for 2/26/2026:
Today's curated articles span a wide range of pressing healthcare topics. On the fraud and oversight front, a Russian citizen in Texas faces charges in a major Medicare billing scheme, while Colorado's Medicaid spending has doubled over a decade despite modest enrollment growth, and Texas AG Paxton has sued a hospital over alleged gender-affirming care billed to Medicaid.
Politically, Democrats are preparing health oversight subpoenas ahead of midterms, Senator Kaine is criticizing Medicaid cuts hurting Virginians, and Trump's drug pricing claims face scrutiny. Medicaid policy is under pressure nationwide, with Western states worried about disability service reductions, Indiana tightening eligibility verification, and advocacy organizations warning about the "One Big Beautiful Bill Act."
On AI, multiple articles examine ChatGPT Health's triage failures, CMS's RFI on AI for Medicare plan selection, CZI's billion-dollar investment in a human cell atlas, and a Merck-Mayo Clinic AI drug discovery collaboration. Telehealth continues to expand, with interstate licensure compacts gaining traction, mobile telemedicine doubling HCV treatment rates in rural areas, and Medicare beneficiaries using telehealth broadly.
Gene therapy holds promise but remains inaccessible due to cost and insurance barriers. Declining vaccination rates are fueling measles resurgence. Microplastics were found in prostate tumors, and a Louisiana mifepristone lawsuit threatens national telehealth abortion access. Employers are exploring direct contracting, while Kaiser Permanente workers end a month-long strike. Rural health transformation funding is being deployed in South Dakota and Delaware.
See back issues of Daily C.R.A.P. on our website right here in the archive.
As of today, C.R.A.P. now has 199 subscribers
Want to drop us a line? E-Mail Us
Click here for ALL articles added to C.R.A.P. in the past 24 hours